Franco Folli
Papers
1
Total Citations
6
H-Index
1
About
Franco Folli is a leading researcher in neuropsychopharmacology, with a primary focus on treatment-resistant depression and the therapeutic potential of novel glutamatergic agents. His major contributions center on the rapid-acting antidepressant effects of esmethadone (REL-1017), particularly its ability to reduce dissociative symptoms in patients with major depressive disorder who have not responded to standard antidepressants. This work is groundbreaking because it addresses a critical gap: dissociative disorders and dissociative states are highly prevalent—affecting nearly 29% of psychiatric outpatients—yet remain vastly underdiagnosed, with only 5% receiving a prior diagnosis. Folli’s research highlights the potential of esmethadone to provide rapid relief for this underserved population, opening new avenues for treating complex, comorbid depressive conditions. His 2022 paper has already garnered 6 citations, signaling growing interest in his findings. By targeting both depressive and dissociative symptoms, Folli is helping to reshape how clinicians understand and treat refractory mood disorders, offering hope for patients who have exhausted conventional options.
Research Focus
Key Achievements
Top Papers
- 1